staggered titration Cycle driver GI tolerance sets the pace Retatrutide Loading 2 mg 4 mg 8 mg (weeks 1-12) Frequency Once weekly Maintenance 12 mg weekly Route SubQ Cagrilintide Loading Start Week 9: 0.25 0.5 1.0 1.7 mg Frequency Once weekly Maintenance 2.4 mg weekly Route SubQ Weekly Schedule Example (Maintenance Phase) Monday Retatrutide 12 mg (one site) + Cagrilintide 2.4 mg (different site) Tuesday No injections Wednesday No injections Thursday No injections Friday No injections Saturday No injections Sunday No injections Both compounds are once-weekly
Tfilin M, Sudai E, Merenlender A, Gispan I, Yadid G, Turgeman G
Andrew Huberman's engaging presentation quality
or Are accompanied by symptoms such as loud snoring, pauses in breathing, or excessive daytime sleepiness Seek consultation with a healthcare provider or sleep specialist
The stability and shelf-life of reconstituted tirzepatide powder have not been established through FDA-reviewed studies, meaning the medication may degrade unpredictably, losing potency or affecting safety
